Global Pharma and Health Care Market Growth (Status and Outlook) 2023-2029

Global Pharma and Health Care Market Growth (Status and Outlook) 2023-2029

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.
In this report, we mainly study the pharma and healthcare product.
LPI (LP Information)' newest research report, the “Pharma and Health Care Industry Forecast” looks at past sales and reviews total world Pharma and Health Care sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharma and Health Care sales for 2023 through 2029. With Pharma and Health Care sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharma and Health Care industry.
This Insight Report provides a comprehensive analysis of the global Pharma and Health Care landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharma and Health Care portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharma and Health Care market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharma and Health Care and breaks down the forecast by format, by prescription, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharma and Health Care.
The global Pharma and Health Care market size is projected to grow from US$ 1218780 million in 2022 to US$ 1620040 million in 2029; it is expected to grow at a CAGR of 4.1% from 2023 to 2029.
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharma and Health Care market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by format
Bottle
Blister
Others
Segmentation by prescription
OTC Drugs
Prescription Drugs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas

Please note: The report will take approximately 2 business days to prepare and deliver.